1 – 10 of 320
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
(
- Contribution to journal › Article
-
Mark
The effect of dopaminergic medication on gambling disorder and impulse control: Epidemiological, clinical, and animal studies
2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Levodopa–entacapone–carbidopa intestinal gel : Data from the Swedish national registry for Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in Sweden
2025) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
-
Mark
Conversion between NMSS and MDS-NMS in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Simultaneous Nonmotor Symptoms Do Not Affect General Validity but Interpretation of the Parkinson's Disease Motor Diary
(
- Contribution to journal › Article
-
Mark
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
(
- Contribution to journal › Article
- 2024
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article